RPS2 and neurodegenerative disease: The observed down-regulation of protein synthesis and RNA processing pathways as a consequence of CA3 overexpression, along with RPS2 being identified as a binding partner, may also offer neuroprotection through several synergistic mechanisms, including the reduction in toxic protein accumulation, suppressing pathways that lead to neurodegenerative disease and decreasing cellular stress [44,45,46].